Nexalin appoints Carolyn Shelton as SVP, clinical, quality, regulatory affairs

Nexalin Technology announces the appointment of Carolyn Shelton as Senior Vice President of Clinical, Quality & Regulatory Affairs. In her role, she will oversee all clinical studies, quality systems, and regulatory submissions, ensuring Nexalin’s commitment to innovation, safety, and excellence as the Company prepares to pursue global regulatory clearances and future FDA Breakthrough Device designations for its Deep Intracranial Frequency Stimulation technology. At Openwater Health, LLC, she served as Vice President of Regulatory, Quality, and Clinical.